Market Research Report

Global Adult Vaccine Market Report By Type (Preventive Vaccine And Therapeutic Vaccine), By Disease (Influenza, Meningococcal, Cervical Cancer, Zoster Shingles, Pneumococcal, Hepatitis, Measles, Mumps, Rubella And Varicella (MMRV), And Diphtheria, Tetanus, Pertussis (DTP)) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

ID:VMR11210086
April 2021
Report Formats: Report Formats

Rising prevalence of infectious diseases in the adult population is a prominent factor driving the market growth. Increasing investment in R&D by governmental bodies for the development of novel drugs and vaccine is further boosting the market growth. Also, rising awareness among the population regarding the advantages of vaccination is further pushing the market growth uphill. Favorable governmental support by arranging free campaign for vaccination is again fueling the market growth.

The latest report by Value Market Research expects the Global Adult Vaccine Market was valued at USD 15 billion in 2017 and is likely to reach USD 22.5 billion by 2024 with CAGR of 5%.
 
THERAPEUTIC VACCINES DOMINATED THE SEGMENT
In 2017, therapeutic vaccine led the segment and has accounted for X.X% of the total market share owing to its ability to induce an immune response and treat virus-infected cells is driving the market growth.
 
Influenza emerged as the leading disease
Influenza dominated the disease segment and has accounted for over 15% of the total market share.  Rising cases of acute respiratory infection, asthma, pneumonia, sinus problems, and other illness majorly caused by influenza are majorly driving the market growth.
 
NORTH AMERICA DOMINATED THE REGIONAL MARKET
Geographically, North America led the market and has accounted for X.X% of the total market share. The North American market is majorly driven owing to improved research infrastructure coupled with increased expenditure on healthcare. Rising initiates by the government for promoting vaccination is further fueling the regional market growth.
 
KEY PLAYERS OF THE MARKET
AstraZeneca Plc., Bharat Biotech, CSL Limited, Dynavax Technologies Corporation, GlaxoSmithKline, ImmunoBiology Ltd., Johnson & Johnson, Medimmune, Merck and Co., Novartis, Pfizer, Sanofi Pasteur and Serum Institute of India are the key players of the Adult Vaccine market.

As per this study the Global Adult Vaccine Market was valued at USD XX BN (by revenue) in 2021 and is anticipated to reach USD XX BN by 2028 with a CAGR of XX%.
 
Vaccine refers to a biological preparation that includes inactive antigen used to create an immune response. Adult vaccines impart immunity in the adult population from various fatal infectious diseases. Vaccination in adults varies depending upon the age, lifestyle, and health condition of the individual. Adult vaccines are used to provide immunity against diphtheria, influenza, hepatitis A & B, human papillomavirus (HPV), mumps, measles, rubella And varicella {MMRV}, and other infectious diseases.
 
Market Dynamics
 
Rising prevalence of vaccine-preventable disease in adults leading to increased demand for novel vaccines is driving the market growth. Governmental initiates and free-campaign towards awareness of vaccines among the population is further fueling the market growth. Also, Governmental investment in R&D for the development of vaccines for fatal diseases is boosting the market growth. However, lack of skilled professional and side effects associated with the certain vaccine is expected to hinder the market growth.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of adult vaccine.
 
Market Segmentation
 
The broad adult vaccine market has been sub-grouped into type and disease. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Type
  • Preventive Vaccine
  • Therapeutic Vaccine
 
By Disease
  • Influenza
  • Meningococcal
  • Cervical Cancer
  • Zoster Shingles
  • Pneumococcal
  • Hepatitis, Measles, Mumps, Rubella And Varicella (MMRV)
  • Diphtheria, Tetanus, Pertussis (DTP)
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for adult vaccine in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Global Adult Vaccine Market Share by Region (Representative Graph)
 
Global Adult Vaccine Market Share
 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the adult vaccine market include AstraZeneca Plc., Bharat Biotech, CSL Limited, Dynavax Technologies Corporation, GlaxoSmithKline, ImmunoBiology Ltd., Johnson & Johnson, Medimmune, Merck and Co., Novartis, Pfizer, Sanofi Pasteur and Serum Institute of India. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.


METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand. 

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . ADULT VACCINE – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 Market Attractiveness Analysis By Type
           3.7.2 Market Attractiveness Analysis By Disease
           3.7.3 Market Attractiveness Analysis By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic 
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL ADULT VACCINE MARKET ANALYSIS BY TYPE
       6.1 Overview by Type
       6.2 Historical and Forecast Data
       6.3 Analysis by Type
       6.4 Preventive Vaccine Historic and Forecast Sales by Regions
       6.6 Therapeutic Vaccine Historic and Forecast Sales by Regions
 
7 . GLOBAL ADULT VACCINE MARKET ANALYSIS BY DISEASE
       7.1 Overview by Disease
       7.2 Historical and Forecast Data
       7.3 Analysis by Disease
       7.4 Influenza Historic and Forecast Sales by Regions
       7.5 Meningococcal Historic and Forecast Sales by Regions
       7.6 Cervical Cancer Historic and Forecast Sales by Regions
       7.7 Zoster Shingles Historic and Forecast Sales by Regions
       7.8 Pneumococcal Historic and Forecast Sales by Regions
       7.9 Hepatitis Measles Mumps Rubella And Varicella (MMRV) Historic and Forecast Sales by Regions
       7.10. Diphtheria Tetanus Pertussis (DTP) Historic and Forecast Sales by Regions
 
8 . GLOBAL ADULT VACCINE MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America Sales Analysis
           8.3.1. Overview, Historic and Forecast Sales Analysis
           8.3.2. North America By Segment Sales Analysis
           8.3.3. North America By Country Sales Analysis
           8.3.4. United State Sales Analysis
           8.3.5. Canada Sales Analysis
           8.3.6. Mexico Sales Analysis
       8.4. Europe Sales Analysis
           8.4.1. Overview, Historic and Forecast Sales Analysis
           8.4.2. Europe by Segment Sales Analysis
           8.4.3. Europe by Country Sales Analysis
           8.4.4. United Kingdom Sales Analysis
           8.4.5. France Sales Analysis
           8.4.6. Germany Sales Analysis
           8.4.7. Italy Sales Analysis
           8.4.8. Russia Sales Analysis
           8.4.9. Rest Of Europe Sales Analysis
       8.5. Asia Pacific Sales Analysis
           8.5.1. Overview, Historic and Forecast Sales Analysis
           8.5.2. Asia Pacific by Segment Sales Analysis
           8.5.3. Asia Pacific by Country Sales Analysis
           8.5.4. China Sales Analysis
           8.5.5. India Sales Analysis
           8.5.6. Japan Sales Analysis
           8.5.7. South Korea Sales Analysis
           8.5.8. Australia Sales Analysis
           8.5.9. Rest Of Asia Pacific Sales Analysis
       8.6. Latin America Sales Analysis
           8.6.1. Overview, Historic and Forecast Sales Analysis
           8.6.2. Latin America by Segment Sales Analysis
           8.6.3. Latin America by Country Sales Analysis
           8.6.4. Brazil Sales Analysis
           8.6.5. Argentina Sales Analysis
           8.6.6. Peru Sales Analysis
           8.6.7. Chile Sales Analysis
           8.6.8. Rest of Latin America Sales Analysis
       8.7. Middle East & Africa Sales Analysis
           8.7.1. Overview, Historic and Forecast Sales Analysis
           8.7.2. Middle East & Africa by Segment Sales Analysis
           8.7.3. Middle East & Africa by Country Sales Analysis
           8.7.4. Saudi Arabia Sales Analysis
           8.7.5. UAE Sales Analysis
           8.7.6. Israel Sales Analysis
           8.7.7. South Africa Sales Analysis
           8.7.8. Rest Of Middle East And Africa Sales Analysis
 
9 . COMPETITIVE LANDSCAPE OF THE ADULT VACCINE COMPANIES
       9.1. Adult Vaccine Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF ADULT VACCINE INDUSTRY
       10.1. Top 10  Company Share Analysis
       10.2. Market Concentration Rate
       10.3. AstraZeneca Plc.
           10.3.1. Company Overview
           10.3.2. Company Revenue
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Bharat Biotech
           10.4.1. Company Overview
           10.4.2. Company Revenue
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. CSL Limited
           10.5.1. Company Overview
           10.5.2. Company Revenue
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Dynavax Technologies Corporation
           10.6.1. Company Overview
           10.6.2. Company Revenue
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. GlaxoSmithKline
           10.7.1. Company Overview
           10.7.2. Company Revenue
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. ImmunoBiology Ltd.
           10.8.1. Company Overview
           10.8.2. Company Revenue
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. Johnson & Johnson
           10.9.1. Company Overview
           10.9.2. Company Revenue
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. Medimmune
           10.10.1. Company Overview
           10.10.2. Company Revenue
           10.10.3. Products
           10.10.4. Recent Developments
       10.11. Merck and Co
           10.11.1. Company Overview
           10.11.2. Company Revenue
           10.11.3. Products
           10.11.4. Recent Developments
       10.12. Novartis
           10.12.1. Company Overview
           10.12.2. Company Revenue
           10.12.3. Products
           10.12.4. Recent Developments
       10.13. Pfizer
           10.13.1. Company Overview
           10.13.2. Company Revenue
           10.13.3. Products
           10.13.4. Recent Developments
       10.14. Sanofi Pasteur
           10.14.1. Company Overview
           10.14.2. Company Revenue
           10.14.3. Products
           10.14.4. Recent Developments
       10.15. Serum Institute of India
           10.15.1. Company Overview
           10.15.2. Company Revenue
           10.15.3. Products
           10.15.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES
 

  •  Market Snapshot
  •  Drivers : Impact Analysis
  •  Restraints : Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  COVID-19 Impact Analysis by Production, Import, Export and Demand
  •  Pre V/S Post COVID-19
  •  Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  •  COVID-19: Micro and Macro Factor Analysis
  •  Analysis by Type (USD MN)
  •  Preventive Vaccine Market Sales by Geography (USD MN)
  •  Therapeutic Vaccine Market Sales by Geography (USD MN)
  •  Analysis Market by Disease (USD MN)
  •  Influenza Market Sales by Geography (USD MN)
  •  Meningococcal Market Sales by Geography (USD MN)
  •  Cervical Cancer Market Sales by Geography (USD MN)
  •  Zoster Shingles Market Sales by Geography (USD MN)
  •  Pneumococcal Market Sales by Geography (USD MN)
  •  Hepatitis Measles Mumps Rubella And Varicella (MMRV) Market Sales by Geography (USD MN)
  •  Diphtheria Tetanus Pertussis (DTP) Market Sales by Geography (USD MN)
  •  Global Adult Vaccine Market Sales by Geography (USD MN)
  •  North America Market Analysis (USD MN)
  •  United State Market Analysis (USD MN)
  •  Canada Market Analysis (USD MN)
  •  Mexico Market Analysis (USD MN)
  •  Europe Market Analysis (USD MN)
  •  Europe Market Estimate by Country (USD MN)
  •  United Kingdom Market Analysis (USD MN)
  •  France Market Analysis (USD MN)
  •  Germany Market Analysis (USD MN)
  •  Italy Market Analysis (USD MN)
  •  Russia Market Analysis (USD MN)
  •  Spain Market Analysis (USD MN)
  •  Rest of Europe Market Analysis (USD MN)
  •  Asia Pacific Market Analysis (USD MN)
  •  China Market Analysis (USD MN)
  •  Japan Market Analysis (USD MN)
  •  India Market Analysis (USD MN)
  •  South Korea Market Analysis (USD MN)
  •  Australia Market Analysis (USD MN)
  •  Rest of Asia Pacific Market Analysis (USD MN)
  •  Latin America Market Analysis (USD MN)
  •  Brazil Market Analysis (USD MN)
  •  Argentina Market Analysis (USD MN)
  •  Peru Market Analysis (USD MN)
  •  Chile Market Analysis (USD MN)
  •  Rest of Latin America Market Analysis (USD MN)
  •  Middle East & Africa Market Analysis (USD MN)
  •  Saudi Arabia Market Analysis (USD MN)
  •  UAE Market Analysis (USD MN)
  •  Israel Market Analysis (USD MN)
  •  South Africa Market Analysis (USD MN)
  •  Rest of Middle East and Africa Market Analysis (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisito
 
 LIST OF FIGURES
 
  •  Research Scope of Adult Vaccine Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Adult Vaccine Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Type
  •  Market Attractiveness Analysis by Disease
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Market Analysis by Type (USD MN)
  •  Preventive Vaccine Market Sales by Geography (USD MN)
  •  Therapeutic Vaccine Market Sales by Geography (USD MN)
  •  Global Market Analysis by Disease (USD MN)
  •  Influenza Market Sales by Geography (USD MN)
  •  Meningococcal Market Sales by Geography (USD MN)
  •  Cervical Cancer Market Sales by Geography (USD MN)
  •  Zoster Shingles Market Sales by Geography (USD MN)
  •  Pneumococcal Market Sales by Geography (USD MN)
  •  Hepatitis Measles Mumps Rubella And Varicella (MMRV) Market Sales by Geography (USD MN)
  •  Diphtheria Tetanus Pertussis (DTP) Market Sales by Geography (USD MN)
  •  Global Market by Revenue
  •  North America Market by Revenue
  •  Europe Market by Revenue
  •  Asia Pacific Market by Revenue
  •  Latin America Market by Revenue
  •  Middle East & Africa Market by Revenue
  •  Recent Development in Industry
  •  Top 10  Company Share Analysis
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials